DYSLIPIDEMIA IS A PROTECTIVE FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS

摘要

First, we would like to point out that the observed protective effect of dyslipidemia observed in our study was not due to any pharmacoiogic interference. For more than a decade, we have been considering a possible worsening effect of statins that has been recently confirmed and we systematically stop this family of drugs in our patients at first visit.2 Thus, in the published study, all patients included were free of statin medication during the whole study.1 This strongly suggests that the protective effect of dyslipidemia is not due to a higher frequency of statin therapy in the low LDL/HDL group of patients.